Release Date: 25/07/18 09:39 Summary: July 2018 Investor Presentation Price Sensitive: No Download Document 2.2MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%